Transplant trial aims to free brittle diabetes patients from insulin shots
NCT ID NCT00160732
Summary
This study is testing the safety of transplanting insulin-producing cells from donors into adults with severe, unstable type 1 diabetes. The goal is to see if this procedure can help control blood sugar levels, reduce or eliminate the need for insulin injections, and prevent dangerous episodes of low blood sugar. Researchers are also evaluating a specific combination of anti-rejection medications to support the transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The University of Chicago Hospitals
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.